| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 8.01e-06 | 6 | 149 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.80e-05 | 151 | 149 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.32e-05 | 46 | 149 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 4.57e-05 | 27 | 149 | 4 | GO:0004683 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.23e-05 | 129 | 149 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | 3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity | 5.53e-05 | 2 | 149 | 2 | GO:0004119 | |
| GeneOntologyMolecularFunction | isomerase activity | 9.90e-05 | 192 | 149 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.06e-04 | 18 | 149 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.29e-04 | 4 | 149 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity | 5.45e-04 | 5 | 149 | 2 | GO:0003831 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | PACSIN1 CAMK2B CAMK2D HSPH1 TRPC5 SPTBN2 GOLGA6C GOLGA6B KATNAL1 ADGRV1 RAB14 FMNL2 IFT88 TUBGCP3 PKD2 DIAPH1 MYH15 HCLS1 PACSIN2 | 5.45e-04 | 1099 | 149 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | PMS1 HSPH1 UBA2 MCM3 KATNAL1 ACSS2 DDX46 ERCC6L2 MYH15 ATP11C CHD6 MORC3 ATP2A1 | 7.09e-04 | 614 | 149 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | gated channel activity | 9.25e-04 | 334 | 149 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 9.85e-04 | 59 | 149 | 4 | GO:0001222 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.11e-03 | 343 | 149 | 9 | GO:0005261 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 2.07e-05 | 77 | 150 | 6 | GO:0051289 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 PRICKLE1 PACSIN1 CAMK2A CAMK2B TRPC5 GOLGA6C ANO1 GOLGA6B ECE1 IL1RAPL1 PTPRD DIAPH1 KNDC1 EIF2AK4 PRKG1 MUC3A PACSIN2 | 3.25e-05 | 826 | 150 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | meiotic cell cycle | PDE3A CAMK2B GOLGA6C MCM3 GOLGA6B TEX15 RMI1 TUBGCP3 XRN1 TOP3A RAD21 | 5.24e-05 | 350 | 150 | 11 | GO:0051321 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 PRICKLE1 PACSIN1 CAMK2A CAMK2B TRPC5 GOLGA6C ANO1 GOLGA6B ECE1 AP3B1 FMNL2 IL1RAPL1 C1GALT1C1 PTPRD IFT88 DIAPH1 KNDC1 EIF2AK4 PRKG1 MUC3A PACSIN2 | 5.31e-05 | 1194 | 150 | 22 | GO:0000902 |
| GeneOntologyBiologicalProcess | sexual reproduction | PDE3A CALR3 IL18 CATSPERE CAMK2B CYP51A1 LYZL6 GOLGA6C AKAP3 MCM3 GOLGA6B KATNAL1 TEX15 AP3B1 RMI1 IFT88 TUBGCP3 TTC12 XRN1 PARN PRKG1 TOP3A RAD21 | 7.55e-05 | 1312 | 150 | 23 | GO:0019953 |
| GeneOntologyBiologicalProcess | calcium ion transport | TMC2 CACNA2D2 CAMK2A CAMK2B CAMK2D CAMK2G TRPC5 RYR1 RYR3 PKD2 DIAPH1 ATP2A1 CACNA2D3 | 9.14e-05 | 509 | 150 | 13 | GO:0006816 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 1.15e-04 | 150 | 150 | 7 | GO:0050773 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | RANBP2 PDE3A PDE3B CALR3 IL18 SRSF4 SRSF5 SRSF6 CAMK2A PIK3R3 HMGCS1 NR4A1 EZH2 IFIT1 DENND4C RYR1 RYR3 MTHFR PKD2 XRN1 DIAPH1 ATP2A1 | 1.34e-04 | 1272 | 150 | 22 | GO:1901698 |
| GeneOntologyBiologicalProcess | positive regulation of oocyte development | 1.57e-04 | 3 | 150 | 2 | GO:0060282 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 1.68e-04 | 71 | 150 | 5 | GO:0021695 | |
| GeneOntologyBiologicalProcess | dendrite development | PRICKLE1 PACSIN1 CAMK2A CAMK2B TRPC5 EZH2 IL1RAPL1 PTPRD KNDC1 PRKG1 | 1.75e-04 | 335 | 150 | 10 | GO:0016358 |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.78e-04 | 113 | 150 | 6 | GO:0051262 | |
| GeneOntologyBiologicalProcess | presynapse organization | 1.92e-04 | 73 | 150 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 2.18e-04 | 75 | 150 | 5 | GO:0050982 | |
| GeneOntologyBiologicalProcess | relaxation of muscle | 2.43e-04 | 42 | 150 | 4 | GO:0090075 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 2.78e-04 | 173 | 150 | 7 | GO:0009581 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 2.91e-04 | 44 | 150 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 2.98e-04 | 175 | 150 | 7 | GO:0009582 | |
| GeneOntologyBiologicalProcess | regulation of oocyte development | 3.12e-04 | 4 | 150 | 2 | GO:0060281 | |
| GeneOntologyBiologicalProcess | regulation of oogenesis | 3.12e-04 | 4 | 150 | 2 | GO:1905879 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 1.27e-08 | 5 | 150 | 4 | GO:0005954 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 7.98e-07 | 45 | 150 | 6 | GO:0033017 | |
| GeneOntologyCellularComponent | calcium channel complex | 9.33e-07 | 73 | 150 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.32e-06 | 88 | 150 | 7 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.84e-05 | 114 | 150 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GDPD1 RANBP2 PACSIN1 CAMK2D PCLO SPTBN2 GOLGA6C MCM3 GOLGA6B ADGRV1 RAB14 ECE1 TRAPPC2B RYR1 RYR3 AATK PRKAR2A PRKAR2B TRAPPC2 | 4.12e-05 | 934 | 150 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | cation channel complex | CATSPERE CACNA2D2 TRPC5 GRIK2 RYR1 RYR3 PKD2 ATP2A1 CACNA2D3 | 5.17e-05 | 235 | 150 | 9 | GO:0034703 |
| GeneOntologyCellularComponent | glutamatergic synapse | PRICKLE1 PACSIN1 CAMK2A CAMK2B PCLO SPTBN2 ANO1 ITGA8 GRIK2 IL1RAPL1 PTPRD IL1RAPL2 PRKAR2A PRKAR2B PLEKHA5 PARN PACSIN2 | 8.18e-05 | 817 | 150 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CATSPERE CACNA2D2 TRPC5 ANO1 GRIK2 RYR1 RYR3 PKD2 ATP2A1 CACNA2D3 GABRA6 | 9.24e-05 | 378 | 150 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | neuronal cell body | CAMK2A CAMK2B CAMK2D PCLO TRPC5 SPTBN2 GOLGA6C ITGA8 GOLGA6B GRIK2 XRN1 KNDC1 PRKAR2B WDFY3 CTSV PMM1 GABRA6 | 1.06e-04 | 835 | 150 | 17 | GO:0043025 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | CBLL1 CUL1 MBTD1 PDE3B PRICKLE1 CAMK2A IARS1 CAMK2B CAMK2D CAMK2G MCM3 TRAPPC2B PHF20L1 KNDC1 PRKAR2A PRKAR2B TTI1 TRAPPC2 | 2.15e-04 | 972 | 150 | 18 | GO:0140535 |
| GeneOntologyCellularComponent | RecQ family helicase-topoisomerase III complex | 3.04e-04 | 4 | 150 | 2 | GO:0031422 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.29e-04 | 46 | 150 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | B4GALT2 PACSIN1 PCLO GOLGA6C GOLGA6B RAB14 AP3B1 IFT88 AP3B2 PACSIN2 ECE2 | 3.64e-04 | 443 | 150 | 11 | GO:0098791 |
| GeneOntologyCellularComponent | cell body | CAMK2A CAMK2B CAMK2D PCLO TRPC5 SPTBN2 GOLGA6C ITGA8 GOLGA6B GRIK2 XRN1 KNDC1 PRKAR2B WDFY3 CTSV PMM1 GABRA6 | 3.73e-04 | 929 | 150 | 17 | GO:0044297 |
| GeneOntologyCellularComponent | neuron to neuron synapse | PRICKLE1 PACSIN1 CAMK2A CAMK2B CAMK2G PCLO ITGA8 GRIK2 IL1RAPL1 PTPRD PLEKHA5 GABRA6 | 4.02e-04 | 523 | 150 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | DNA helicase complex | 5.04e-04 | 5 | 150 | 2 | GO:0033202 | |
| GeneOntologyCellularComponent | transporter complex | CATSPERE CACNA2D2 TRPC5 ANO1 GRIK2 RYR1 RYR3 PKD2 ATP11C ATP2A1 CACNA2D3 GABRA6 | 6.28e-04 | 550 | 150 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | postsynaptic specialization | PRICKLE1 PACSIN1 CAMK2A CAMK2B CAMK2G PCLO ITGA8 GRIK2 IL1RAPL1 PLEKHA5 GABRA6 | 1.04e-03 | 503 | 150 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | somatodendritic compartment | CHL1 CAMK2A CAMK2B CAMK2D PCLO TRPC5 SPTBN2 GOLGA6C ITGA8 GOLGA6B GRIK2 IL1RAPL1 XRN1 KNDC1 PRKAR2B WDFY3 CTSV PMM1 GABRA6 | 1.29e-03 | 1228 | 150 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CATSPERE CACNA2D2 TRPC5 ANO1 GRIK2 RYR1 RYR3 PKD2 ATP2A1 CACNA2D3 GABRA6 | 1.42e-03 | 523 | 150 | 11 | GO:1902495 |
| GeneOntologyCellularComponent | ribbon synapse | 1.54e-03 | 32 | 150 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | postsynaptic density | PRICKLE1 PACSIN1 CAMK2A CAMK2B CAMK2G PCLO ITGA8 GRIK2 IL1RAPL1 PLEKHA5 | 1.58e-03 | 451 | 150 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | trans-Golgi network | 1.68e-03 | 306 | 150 | 8 | GO:0005802 | |
| GeneOntologyCellularComponent | junctional membrane complex | 1.78e-03 | 9 | 150 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | presynapse | CACNA2D2 PACSIN1 CAMK2A PCLO TRPC5 SPTBN2 ANO1 GRIK2 NR4A1 RAB14 PTPRD AP3B2 DIAPH1 CACNA2D3 GABRA6 | 1.80e-03 | 886 | 150 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 2.22e-03 | 10 | 150 | 2 | GO:0005952 | |
| GeneOntologyCellularComponent | asymmetric synapse | PRICKLE1 PACSIN1 CAMK2A CAMK2B CAMK2G PCLO ITGA8 GRIK2 IL1RAPL1 PLEKHA5 | 2.38e-03 | 477 | 150 | 10 | GO:0032279 |
| Domain | CaMKII_AD | 3.49e-09 | 4 | 145 | 4 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 3.49e-09 | 4 | 145 | 4 | IPR013543 | |
| Domain | TPR_8 | 1.68e-07 | 53 | 145 | 7 | PF13181 | |
| Domain | - | 2.36e-06 | 13 | 145 | 4 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 4.45e-06 | 15 | 145 | 4 | IPR032710 | |
| Domain | TPR | 7.51e-06 | 129 | 145 | 8 | SM00028 | |
| Domain | TPR_repeat | 9.41e-06 | 133 | 145 | 8 | IPR019734 | |
| Domain | TPR-contain_dom | 2.26e-05 | 150 | 145 | 8 | IPR013026 | |
| Domain | - | 3.50e-05 | 207 | 145 | 9 | 1.25.40.10 | |
| Domain | TPR_REGION | 4.47e-05 | 165 | 145 | 8 | PS50293 | |
| Domain | TPR | 4.47e-05 | 165 | 145 | 8 | PS50005 | |
| Domain | AP3_beta | 5.99e-05 | 2 | 145 | 2 | IPR026740 | |
| Domain | AP3B_C | 5.99e-05 | 2 | 145 | 2 | IPR029390 | |
| Domain | AP3B1_C | 5.99e-05 | 2 | 145 | 2 | PF14796 | |
| Domain | AP3B1_C | 5.99e-05 | 2 | 145 | 2 | SM01355 | |
| Domain | TPR_1 | 7.19e-05 | 90 | 145 | 6 | IPR001440 | |
| Domain | TPR_1 | 7.19e-05 | 90 | 145 | 6 | PF00515 | |
| Domain | IL-1_rcpt_fam | 7.23e-05 | 11 | 145 | 3 | IPR015621 | |
| Domain | TPR-like_helical_dom | 8.74e-05 | 233 | 145 | 9 | IPR011990 | |
| Domain | Ryanodine_rcpt | 1.79e-04 | 3 | 145 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.79e-04 | 3 | 145 | 2 | IPR009460 | |
| Domain | RyR | 1.79e-04 | 3 | 145 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.79e-04 | 3 | 145 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.79e-04 | 3 | 145 | 2 | IPR013333 | |
| Domain | cNMP-bd_CS | 2.38e-04 | 16 | 145 | 3 | IPR018488 | |
| Domain | ARM-type_fold | 3.22e-04 | 339 | 145 | 10 | IPR016024 | |
| Domain | VDCC_a2/dsu | 3.56e-04 | 4 | 145 | 2 | IPR013680 | |
| Domain | cAMP_dep_PK_reg_su | 3.56e-04 | 4 | 145 | 2 | IPR012198 | |
| Domain | VGCC_alpha2 | 3.56e-04 | 4 | 145 | 2 | PF08473 | |
| Domain | TIR | 5.50e-04 | 21 | 145 | 3 | SM00255 | |
| Domain | AP_beta | 5.89e-04 | 5 | 145 | 2 | IPR026739 | |
| Domain | VWA_N | 5.89e-04 | 5 | 145 | 2 | IPR013608 | |
| Domain | VWA_N | 5.89e-04 | 5 | 145 | 2 | PF08399 | |
| Domain | SANT | 6.08e-04 | 50 | 145 | 4 | SM00717 | |
| Domain | TIR | 6.33e-04 | 22 | 145 | 3 | PF01582 | |
| Domain | SANT/Myb | 7.07e-04 | 52 | 145 | 4 | IPR001005 | |
| Domain | - | 7.24e-04 | 23 | 145 | 3 | 3.40.50.10140 | |
| Domain | TIR | 8.23e-04 | 24 | 145 | 3 | PS50104 | |
| Domain | RIH_assoc-dom | 8.80e-04 | 6 | 145 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 8.80e-04 | 6 | 145 | 2 | PF08709 | |
| Domain | RIIa | 8.80e-04 | 6 | 145 | 2 | SM00394 | |
| Domain | RIH_assoc | 8.80e-04 | 6 | 145 | 2 | PF08454 | |
| Domain | RIH_dom | 8.80e-04 | 6 | 145 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.80e-04 | 6 | 145 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.80e-04 | 6 | 145 | 2 | IPR015925 | |
| Domain | - | 8.80e-04 | 6 | 145 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.80e-04 | 6 | 145 | 2 | PF01365 | |
| Domain | EF-hand_5 | 9.30e-04 | 25 | 145 | 3 | PF13202 | |
| Domain | TIR_dom | 9.30e-04 | 25 | 145 | 3 | IPR000157 | |
| Domain | Peptidase_M13_C | 1.23e-03 | 7 | 145 | 2 | IPR018497 | |
| Domain | Peptidase_M13 | 1.23e-03 | 7 | 145 | 2 | IPR000718 | |
| Domain | Peptidase_M13_N | 1.23e-03 | 7 | 145 | 2 | PF05649 | |
| Domain | Peptidase_M13_N | 1.23e-03 | 7 | 145 | 2 | IPR008753 | |
| Domain | RIIa | 1.23e-03 | 7 | 145 | 2 | PF02197 | |
| Domain | Peptidase_M13 | 1.23e-03 | 7 | 145 | 2 | PF01431 | |
| Domain | DAD_dom | 1.63e-03 | 8 | 145 | 2 | IPR014767 | |
| Domain | DAD | 1.63e-03 | 8 | 145 | 2 | PS51231 | |
| Domain | CNMP_BINDING_1 | 1.93e-03 | 32 | 145 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 1.93e-03 | 32 | 145 | 3 | PS00889 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 2.04e-03 | 69 | 145 | 4 | IPR020636 | |
| Domain | Drf_GBD | 2.08e-03 | 9 | 145 | 2 | PF06371 | |
| Domain | Drf_FH3 | 2.08e-03 | 9 | 145 | 2 | PF06367 | |
| Domain | FH3_dom | 2.08e-03 | 9 | 145 | 2 | IPR010472 | |
| Domain | GTPase-bd | 2.08e-03 | 9 | 145 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 2.08e-03 | 9 | 145 | 2 | SM01139 | |
| Domain | Drf_GBD | 2.08e-03 | 9 | 145 | 2 | SM01140 | |
| Domain | EF_hand_dom | 2.26e-03 | 232 | 145 | 7 | IPR002048 | |
| Domain | cNMP | 2.30e-03 | 34 | 145 | 3 | SM00100 | |
| Domain | cNMP_binding | 2.30e-03 | 34 | 145 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 2.50e-03 | 35 | 145 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 2.50e-03 | 35 | 145 | 3 | PS50042 | |
| Domain | Pept_asp_AS | 2.59e-03 | 10 | 145 | 2 | IPR025661 | |
| Domain | MIR | 2.59e-03 | 10 | 145 | 2 | PF02815 | |
| Domain | MBT | 2.59e-03 | 10 | 145 | 2 | PF02820 | |
| Domain | MIR_motif | 2.59e-03 | 10 | 145 | 2 | IPR016093 | |
| Domain | Mbt | 2.59e-03 | 10 | 145 | 2 | IPR004092 | |
| Domain | MIR | 2.59e-03 | 10 | 145 | 2 | PS50919 | |
| Domain | MIR | 2.59e-03 | 10 | 145 | 2 | SM00472 | |
| Domain | Pept_his_AS | 3.14e-03 | 11 | 145 | 2 | IPR025660 | |
| Domain | GBD/FH3_dom | 3.14e-03 | 11 | 145 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 3.14e-03 | 11 | 145 | 2 | PS51232 | |
| Domain | cNMP-bd-like | 3.17e-03 | 38 | 145 | 3 | IPR018490 | |
| Domain | - | 4.33e-03 | 261 | 145 | 7 | 1.10.238.10 | |
| Domain | Pept_C1 | 4.41e-03 | 13 | 145 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 4.41e-03 | 13 | 145 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 4.41e-03 | 13 | 145 | 2 | PF00112 | |
| Domain | Peptidase_C1A | 4.41e-03 | 13 | 145 | 2 | IPR013128 | |
| Domain | ARM-like | 5.20e-03 | 270 | 145 | 7 | IPR011989 | |
| Domain | Znf_FYVE_PHD | 5.83e-03 | 147 | 145 | 5 | IPR011011 | |
| Domain | Clathrin/coatomer_adapt-like_N | 5.88e-03 | 15 | 145 | 2 | IPR002553 | |
| Domain | FH2 | 5.88e-03 | 15 | 145 | 2 | PS51444 | |
| Domain | FH2_Formin | 5.88e-03 | 15 | 145 | 2 | IPR015425 | |
| Domain | FH2 | 5.88e-03 | 15 | 145 | 2 | PF02181 | |
| Domain | Adaptin_N | 5.88e-03 | 15 | 145 | 2 | PF01602 | |
| Domain | cAMP_dep_PK_reg_su_I/II_a/b | 5.88e-03 | 15 | 145 | 2 | IPR003117 | |
| Domain | FH2 | 5.88e-03 | 15 | 145 | 2 | SM00498 | |
| Domain | - | 6.14e-03 | 48 | 145 | 3 | 2.60.120.10 | |
| Domain | TPR_2 | 6.88e-03 | 50 | 145 | 3 | PF07719 | |
| Domain | TPR_2 | 6.88e-03 | 50 | 145 | 3 | IPR013105 | |
| Domain | EF-hand-dom_pair | 7.19e-03 | 287 | 145 | 7 | IPR011992 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.56e-07 | 54 | 125 | 7 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.56e-07 | 54 | 125 | 7 | MM15202 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 8.00e-07 | 37 | 125 | 6 | M749 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.19e-06 | 10 | 125 | 4 | M26910 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.50e-06 | 41 | 125 | 6 | M512 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.59e-06 | 103 | 125 | 8 | MM15196 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | CAMK2A CAMK2B CAMK2D CAMK2G TRPC5 ANO1 RYR1 RYR3 ATP11C ATP2A1 | 3.67e-06 | 176 | 125 | 10 | MM15718 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | CAMK2A CAMK2B CAMK2D CAMK2G TRPC5 ANO1 RYR1 RYR3 ATP11C ATP2A1 | 5.19e-06 | 183 | 125 | 10 | M997 |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 5.51e-06 | 14 | 125 | 4 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 5.51e-06 | 14 | 125 | 4 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 7.46e-06 | 15 | 125 | 4 | M47385 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 7.86e-06 | 54 | 125 | 6 | M26911 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 8.41e-06 | 32 | 125 | 5 | M27455 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 8.75e-06 | 55 | 125 | 6 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.08e-05 | 57 | 125 | 6 | MM15643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.28e-05 | 17 | 125 | 4 | M47387 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.01e-05 | 130 | 125 | 8 | M27454 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.01e-05 | 38 | 125 | 5 | M27255 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 2.06e-05 | 19 | 125 | 4 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 2.06e-05 | 19 | 125 | 4 | MM15473 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 2.56e-05 | 20 | 125 | 4 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.14e-05 | 21 | 125 | 4 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 3.14e-05 | 21 | 125 | 4 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.81e-05 | 22 | 125 | 4 | MM15104 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 4.58e-05 | 23 | 125 | 4 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 4.58e-05 | 23 | 125 | 4 | M47512 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 4.58e-05 | 23 | 125 | 4 | M27949 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.86e-05 | 147 | 125 | 8 | MM15854 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.46e-05 | 24 | 125 | 4 | M47509 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 5.76e-05 | 47 | 125 | 5 | M39531 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.88e-05 | 151 | 125 | 8 | M39329 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 6.45e-05 | 25 | 125 | 4 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 6.45e-05 | 25 | 125 | 4 | M47511 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 6.76e-05 | 154 | 125 | 8 | MM15974 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNA2D2 CAMK2A CAMK2B CAMK2D CAMK2G GRIK2 IL1RAPL1 PTPRD IL1RAPL2 PRKAR2A PRKAR2B CACNA2D3 GABRA6 | 7.22e-05 | 411 | 125 | 13 | M735 |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 7.40e-05 | 156 | 125 | 8 | M39475 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 1.02e-04 | 28 | 125 | 4 | M837 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 1.02e-04 | 28 | 125 | 4 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.02e-04 | 28 | 125 | 4 | M47508 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.10e-04 | 165 | 125 | 8 | MM15026 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.18e-04 | 29 | 125 | 4 | MM15028 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | CACNA2D2 CAMK2A CAMK2B CAMK2D CAMK2G GRIK2 PRKAR2A PRKAR2B CACNA2D3 GABRA6 | 1.44e-04 | 270 | 125 | 10 | M15514 |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.46e-04 | 90 | 125 | 6 | M6467 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.54e-04 | 31 | 125 | 4 | M7223 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.65e-04 | 92 | 125 | 6 | MM14951 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.75e-04 | 32 | 125 | 4 | M27900 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.86e-04 | 94 | 125 | 6 | M2843 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNA2D2 CAMK2A CAMK2B CAMK2D CAMK2G GRIK2 IL1RAPL1 PTPRD IL1RAPL2 CACNA2D3 GABRA6 | 1.92e-04 | 335 | 125 | 11 | MM14503 |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.98e-04 | 33 | 125 | 4 | M39875 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.22e-04 | 34 | 125 | 4 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.49e-04 | 35 | 125 | 4 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.49e-04 | 35 | 125 | 4 | MM15109 | |
| Pathway | KEGG_GLIOMA | 2.73e-04 | 65 | 125 | 5 | M1835 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 2.73e-04 | 65 | 125 | 5 | M38994 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.75e-04 | 101 | 125 | 6 | M27253 | |
| Pathway | WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2 | 3.50e-04 | 16 | 125 | 3 | M39484 | |
| Pathway | PID_IFNG_PATHWAY | 4.21e-04 | 40 | 125 | 4 | M161 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.49e-04 | 203 | 125 | 8 | M5485 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | CAMK2A CAMK2B CAMK2D CAMK2G PIK3R3 NR4A1 EZH2 USP7 PRKAR2A PRKAR2B | 4.70e-04 | 313 | 125 | 10 | M27867 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.80e-04 | 205 | 125 | 8 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.80e-04 | 211 | 125 | 8 | MM14502 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 6.08e-04 | 44 | 125 | 4 | M39845 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 6.08e-04 | 44 | 125 | 4 | M27934 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 6.63e-04 | 45 | 125 | 4 | M27623 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 6.95e-04 | 20 | 125 | 3 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 6.95e-04 | 20 | 125 | 3 | MM14991 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 8.00e-04 | 82 | 125 | 5 | M27626 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 8.05e-04 | 21 | 125 | 3 | M47949 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 8.46e-04 | 83 | 125 | 5 | MM14819 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.04e-03 | 178 | 125 | 7 | M2890 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 1.05e-03 | 87 | 125 | 5 | M12467 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | B4GALT2 CTSC SPTBN2 GOLGA6C GOLGA6B RENBP PPP6R3 PMM1 TRAPPC2 | 1.19e-03 | 293 | 125 | 9 | MM15120 |
| Pathway | WP_ERBB_SIGNALING | 1.34e-03 | 92 | 125 | 5 | M39715 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.38e-03 | 137 | 125 | 6 | M18155 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.42e-03 | 55 | 125 | 4 | M39763 | |
| Pathway | KEGG_GALACTOSE_METABOLISM | 1.52e-03 | 26 | 125 | 3 | M4377 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 1.59e-03 | 7 | 125 | 2 | M47896 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.77e-03 | 144 | 125 | 6 | MM14501 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 2.10e-03 | 29 | 125 | 3 | M39762 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 2.11e-03 | 8 | 125 | 2 | M10546 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 2.15e-03 | 202 | 125 | 7 | MM15650 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 2.18e-03 | 150 | 125 | 6 | M27440 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 2.25e-03 | 151 | 125 | 6 | M19428 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 2.34e-03 | 63 | 125 | 4 | M27862 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 2.70e-03 | 9 | 125 | 2 | MM1477 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 2.95e-03 | 110 | 125 | 5 | MM15977 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RANBP2 SRSF4 SRSF5 CALU IARS1 CAMK2D CAMK2G HSPH1 SPTBN2 RCN1 UBA2 MCM3 HMGCS1 HNRNPUL1 IPO4 RAB14 TTC1 AP3B1 YARS1 DDX46 DIAPH1 USP7 PRKAR2A PRKAR2B PACSIN2 | 2.78e-11 | 1149 | 150 | 25 | 35446349 |
| Pubmed | CBLL1 RANBP2 BCLAF1 CAMK2A CAMK2B CAMK2D CAMK2G SPTBN2 GOLGA6C MCM3 GOLGA6B GRIK2 IPO4 RAB14 USP10 PTPRD DIAPH1 PRKAR2A PRKAR2B PLEKHA5 PARN WDFY3 PRRC2B | 3.02e-11 | 963 | 150 | 23 | 28671696 | |
| Pubmed | 3.32e-10 | 4 | 150 | 4 | 10381553 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 3.32e-10 | 4 | 150 | 4 | 17367784 | |
| Pubmed | 3.32e-10 | 4 | 150 | 4 | 11889801 | ||
| Pubmed | CUL1 RANBP2 IARS1 HSPH1 MCM3 HNRNPUL1 IPO4 AP3B1 TRIM33 USP10 DDX46 WDHD1 TUBGCP3 DIAPH1 USP7 PRKAR2A PPP6R3 RAD21 | 3.69e-10 | 638 | 150 | 18 | 33239621 | |
| Pubmed | SRSF5 PACSIN1 TNC BCLAF1 CAMK2A IARS1 CAMK2B CAMK2D CAMK2G PCLO HSPH1 SPTBN2 RAB14 AP3B1 FMNL2 YARS1 USP10 AP3B2 XRN1 USP7 KNDC1 PRKAR2A PRKAR2B PLEKHA5 PRRC2B CACNA2D3 | 5.21e-10 | 1431 | 150 | 26 | 37142655 | |
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 11013247 | ||
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 21209221 | ||
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 14722083 | ||
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 18218981 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 1.66e-09 | 5 | 150 | 4 | 16436603 | |
| Pubmed | RANBP2 BCLAF1 CAMK2B CAMK2G PCLO HSPH1 SPTBN2 GOLGA6C RCN1 GOLGA6B RAB14 ECE1 PHF20L1 IFT88 XRN1 MYH15 ATP11C PADI6 CHD6 EIF2AK4 ATP2A1 SKAP2 HCLS1 PRRC2B TRAPPC2 | 3.02e-09 | 1442 | 150 | 25 | 35575683 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 4.95e-09 | 6 | 150 | 4 | 18948074 | |
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 1.15e-08 | 7 | 150 | 4 | 9115241 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL1 PDE3A SRSF5 SRSF6 CALU IARS1 CTSC HSPH1 RCN1 UBA2 MCM3 HNRNPUL1 IPO4 TTC1 AP3B1 CDC37L1 YARS1 WDHD1 DIAPH1 USP7 PRKAR2A TTI1 PACSIN2 PPP6R3 | 1.69e-08 | 1455 | 150 | 24 | 22863883 |
| Pubmed | CUL1 RANBP2 GALE SRSF4 SRSF5 SRSF6 CALU BCLAF1 IARS1 CAMK2D HSPH1 RCN1 MCM3 HMGCS1 HNRNPUL1 AP3B1 USP10 XRN1 DIAPH1 USP7 PRKAR2A PPP6R3 | 2.20e-08 | 1247 | 150 | 22 | 27684187 | |
| Pubmed | 2.30e-08 | 8 | 150 | 4 | 11264466 | ||
| Pubmed | 2.30e-08 | 8 | 150 | 4 | 20668654 | ||
| Pubmed | CUL1 HSPH1 CYP51A1 UBA2 HMGCS1 IPO4 AP3B1 XAB2 MRPS30 TRIM33 TUBGCP3 DIAPH1 PRKAR2B PPP6R3 RAD21 | 2.33e-08 | 560 | 150 | 15 | 35241646 | |
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 12660151 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CUL1 MBTD1 CAMK2B UBA2 MCM3 IPO4 YARS1 TRIM33 RMI1 DIAPH1 USP7 MORC3 TOP3A PRRC2B PPP6R3 | 4.41e-08 | 588 | 150 | 15 | 38580884 |
| Pubmed | 6.84e-08 | 10 | 150 | 4 | 19776387 | ||
| Pubmed | 6.84e-08 | 10 | 150 | 4 | 28361052 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 9882483 | ||
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 7.86e-08 | 3 | 150 | 3 | 9060999 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 10819240 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 20844140 | ||
| Pubmed | CUL1 CAMK2A CAMK2B CAMK2D CAMK2G RCN1 HMGCS1 HNRNPUL1 AP3B1 MTHFR KNDC1 | 9.64e-08 | 304 | 150 | 11 | 32235678 | |
| Pubmed | 1.24e-07 | 89 | 150 | 7 | 36861887 | ||
| Pubmed | 1.60e-07 | 12 | 150 | 4 | 8615909 | ||
| Pubmed | 1.60e-07 | 12 | 150 | 4 | 8665664 | ||
| Pubmed | 1.60e-07 | 12 | 150 | 4 | 12815021 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | RANBP2 IARS1 CAMK2D HSPH1 HNRNPUL1 EZH2 AP3B1 YARS1 USP7 PRKAR2A PARN RAD21 | 1.60e-07 | 394 | 150 | 12 | 27248496 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ZMYND19 SRSF5 SRSF6 CAMK2A IARS1 CAMK2B MCM3 HNRNPUL1 IPO4 RAB14 AP3B1 FMNL2 DENND4C IFT88 PKD2 TTC21B TTI1 PLEKHA5 MORC3 CTSV PRRC2B | 2.68e-07 | 1321 | 150 | 21 | 27173435 |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 8380342 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 21926414 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 9384575 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 14532276 | ||
| Pubmed | RANBP2 PDE3A CALU BCLAF1 HSPH1 MCM3 IPO4 EZH2 DENND4C USP10 PLEKHA5 PARN PPP6R3 | 3.14e-07 | 503 | 150 | 13 | 16964243 | |
| Pubmed | 3.22e-07 | 14 | 150 | 4 | 10373510 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 4.37e-07 | 15 | 150 | 4 | 14622581 | |
| Pubmed | 4.37e-07 | 15 | 150 | 4 | 9481670 | ||
| Pubmed | PMS1 PDE3B SRSF6 CALU BCLAF1 PIK3R3 HSPH1 SPTBN2 CYP51A1 RCN1 HNRNPUL1 IPO4 TTC1 AP3B1 USP10 TUBGCP3 PRKAR2A PRKAR2B PLEKHA5 PACSIN2 PPP6R3 RAD21 | 4.56e-07 | 1487 | 150 | 22 | 33957083 | |
| Pubmed | PMS1 RANBP2 ZFYVE16 CALU GOLM2 PIK3R3 SPTBN2 RCN1 PPM1M AP3B1 CDCA8 DUSP22 PTPRD USP7 TTI1 EIF2AK4 PRRC2B PPP6R3 | 6.97e-07 | 1049 | 150 | 18 | 27880917 | |
| Pubmed | GDPD1 RANBP2 PDE3B CALU IARS1 CAMK2D CAMK2G CTSC CYP51A1 MCM3 IPO4 ECE1 AP3B1 XAB2 TUBGCP3 XRN1 PRKAR2A PLEKHA5 RAD21 | 7.43e-07 | 1168 | 150 | 19 | 19946888 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 11160423 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 19671701 | ||
| Pubmed | PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning. | 7.81e-07 | 5 | 150 | 3 | 28636948 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.93e-07 | 231 | 150 | 9 | 16452087 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RANBP2 SRSF5 SRSF6 IARS1 HSPH1 RCN1 MCM3 RDH13 HNRNPUL1 RAB14 AP3B1 TRAPPC2B XAB2 YARS1 USP10 DDX46 DIAPH1 USP7 CTSV PPP6R3 RAD21 | 8.14e-07 | 1415 | 150 | 21 | 28515276 |
| Pubmed | PDE3A ZFYVE16 CALU IARS1 CTSC HSPH1 CYP51A1 RCN1 RDH13 HNRNPUL1 RAB14 ECE1 XAB2 YARS1 USP10 DIAPH1 PRKAR2A PARN PRRC2B PPP6R3 | 8.49e-07 | 1297 | 150 | 20 | 33545068 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CUL1 RANBP2 SRSF5 SRSF6 CACNA2D2 CALU BCLAF1 IARS1 CAMK2B PCLO HSPH1 MCM3 HNRNPUL1 IPO4 AP3B1 YARS1 USP10 DIAPH1 USP7 PRKAR2A RAD21 | 9.11e-07 | 1425 | 150 | 21 | 30948266 |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 9.70e-07 | 18 | 150 | 4 | 18311135 | |
| Pubmed | CUL1 SRSF4 SRSF5 SRSF6 CALU RCN1 MCM3 IPO4 AP3B1 IFIT1 XAB2 PPP1R3A DDX46 WDHD1 | 1.01e-06 | 653 | 150 | 14 | 33742100 | |
| Pubmed | RANBP2 SRSF4 SRSF5 SPTBN2 HNRNPUL1 IPO4 XAB2 DDX46 XRN1 USP7 PARN PRRC2B PPP6R3 RAD21 | 1.01e-06 | 653 | 150 | 14 | 22586326 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RANBP2 SRSF4 SRSF6 IARS1 HSPH1 UBA2 MCM3 HMGCS1 HNRNPUL1 IPO4 RAB14 AP3B1 XAB2 YARS1 DDX46 DIAPH1 PRKAR2B CHD6 MORC3 RAD21 | 1.09e-06 | 1318 | 150 | 20 | 30463901 |
| Pubmed | CBLL1 MBTD1 SRSF5 CAMK2G HSPH1 GRIK2 HMGCS1 HNRNPUL1 RAB14 EZH2 INO80D XAB2 USP10 DDX46 XRN1 USP7 PARN EIF2AK4 CRAMP1 PPP6R3 | 1.21e-06 | 1327 | 150 | 20 | 32694731 | |
| Pubmed | 1.25e-06 | 244 | 150 | 9 | 28902428 | ||
| Pubmed | COL5A2 RANBP2 PDE3A IARS1 HSPH1 MCM3 RAB14 WDHD1 USP7 PRKAR2A PPP6R3 | 1.41e-06 | 399 | 150 | 11 | 37536630 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RANBP2 SRSF6 CALU BCLAF1 HSPH1 CYP51A1 RCN1 MCM3 HNRNPUL1 IPO4 RAB14 XAB2 TRIM33 USP10 USP7 PARN RAD21 | 1.42e-06 | 989 | 150 | 17 | 36424410 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | CUL1 SRSF4 SRSF5 SRSF6 BCLAF1 IARS1 MCM3 FMNL2 USP10 DDX46 USP7 ATP2A1 | 1.46e-06 | 486 | 150 | 12 | 30940648 |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 16120608 | ||
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 10444070 | ||
| Pubmed | SR proteins: a conserved family of pre-mRNA splicing factors. | 1.56e-06 | 6 | 150 | 3 | 1577277 | |
| Pubmed | Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. | 1.56e-06 | 6 | 150 | 3 | 11972023 | |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 11278869 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | CAMK2A CAMK2G PCLO SPTBN2 IPO4 AP3B1 AP3B2 XRN1 PRKAR2A PRKAR2B TTI1 PPP6R3 | 1.88e-06 | 498 | 150 | 12 | 36634849 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.97e-06 | 332 | 150 | 10 | 32786267 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CUL1 RANBP2 SRSF6 IARS1 CAMK2B CAMK2D CAMK2G HSPH1 CYP51A1 MCM3 RDH13 HNRNPUL1 IPO4 RAB14 USP10 USP7 PRKAR2A SKAP2 PPP6R3 | 2.19e-06 | 1257 | 150 | 19 | 37317656 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CUL1 SRSF5 BCLAF1 CAMK2B CAMK2D CAMK2G HSPH1 CDCA8 USP7 PRKAR2A PRKAR2B MYH15 PARN EIF2AK4 PRKG1 PPP6R3 | 2.21e-06 | 910 | 150 | 16 | 36736316 |
| Pubmed | 2.44e-06 | 340 | 150 | 10 | 24332808 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RANBP2 SRSF5 SRSF6 CALU BCLAF1 RCN1 HNRNPUL1 CDCA8 XAB2 RMI1 DDX46 PHF20L1 TUBGCP3 PRKAR2A MORC3 TOP3A PRRC2B RAD21 | 2.71e-06 | 1155 | 150 | 18 | 20360068 |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 34932950 | ||
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 35163710 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 CUL1 MBTD1 RANBP2 SRSF4 SRSF5 SRSF6 BCLAF1 HNRNPUL1 NR4A1 EZH2 INO80D XAB2 RMI1 DDX46 USP7 CHD6 TOP3A RAD21 | 3.33e-06 | 1294 | 150 | 19 | 30804502 |
| Pubmed | 3.71e-06 | 147 | 150 | 7 | 16959763 | ||
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 4.33e-06 | 8 | 150 | 3 | 19033399 | |
| Pubmed | PRICKLE1 TNC CALU CAMK2G AP3B1 IFIT1 RYR1 IL1RAPL1 C1GALT1C1 WDHD1 CHD6 WDFY3 PRRC2B | 4.35e-06 | 638 | 150 | 13 | 31182584 | |
| Pubmed | PMS1 PDE3B ECE1 EZH2 AP3B1 XAB2 TUBGCP3 XRN1 PLEKHA5 PARN EIF2AK4 TOP3A PRRC2B | 5.32e-06 | 650 | 150 | 13 | 38777146 | |
| Pubmed | 6.48e-06 | 9 | 150 | 3 | 19857271 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 GALE CALU BCLAF1 IARS1 CAMK2D HSPH1 CYP51A1 HMGCS1 HNRNPUL1 IPO4 RAB14 TTC1 IFIT1 XAB2 DDX46 PRKAR2A PRRC2B RAD21 | 7.28e-06 | 1367 | 150 | 19 | 32687490 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | CUL1 RANBP2 CALU IARS1 HSPH1 CYP51A1 RCN1 HMGCS1 IPO4 USP7 PRKAR2A PPP6R3 | 7.57e-06 | 571 | 150 | 12 | 37167062 |
| Pubmed | 8.02e-06 | 63 | 150 | 5 | 34718347 | ||
| Pubmed | CUL1 RANBP2 BCLAF1 UBA2 MCM3 ACSS2 XAB2 YARS1 TRIM33 USP10 DDX46 WDHD1 DIAPH1 USP7 PARN RAD21 | 8.65e-06 | 1014 | 150 | 16 | 32416067 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CBLL1 SRSF6 BCLAF1 IARS1 CAMK2D CAMK2G HSPH1 SPTBN2 MCM3 HNRNPUL1 IPO4 RAB14 XAB2 YARS1 USP10 USP7 PLEKHA5 RAD21 | 8.65e-06 | 1257 | 150 | 18 | 36526897 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 8.90e-06 | 235 | 150 | 8 | 28378594 | |
| Pubmed | Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. | 9.23e-06 | 10 | 150 | 3 | 10983978 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 9.44e-06 | 313 | 150 | 9 | 38270169 | |
| Pubmed | CUL1 TMC2 GANC PACSIN1 CALU CAMK2B CTSC MIER3 RAB14 PPP1R3A IL1RAPL1 PKD2 PRKAR2B EFCAB7 | 9.55e-06 | 794 | 150 | 14 | 11076863 | |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 1.01e-05 | 113 | 150 | 6 | 23403292 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SRSF5 SRSF6 BCLAF1 NR4A1 TTC1 AP3B1 CDC37L1 DENND4C TRIM33 WDHD1 TUBGCP3 XRN1 KNDC1 PRKAR2A PLEKHA5 PPP6R3 | 1.15e-05 | 1038 | 150 | 16 | 26673895 |
| Pubmed | 1.17e-05 | 244 | 150 | 8 | 29884807 | ||
| Pubmed | 1.17e-05 | 244 | 150 | 8 | 30349055 | ||
| Pubmed | 1.26e-05 | 11 | 150 | 3 | 21491429 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.29e-05 | 118 | 150 | 6 | 27377895 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.35e-05 | 179 | 150 | 7 | 36261009 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PMS1 RANBP2 ZFYVE16 BCLAF1 HSPH1 HNRNPUL1 TTC1 XAB2 USP10 DDX46 XRN1 USP7 PRRC2B PPP6R3 RAD21 | 1.37e-05 | 934 | 150 | 15 | 33916271 |
| Pubmed | CUL1 RANBP2 SRSF5 SRSF6 CALU BCLAF1 HSPH1 SPTBN2 RCN1 MCM3 RDH13 HNRNPUL1 IPO4 IFIT1 USP10 DDX46 USP7 PRRC2B PPP6R3 | 1.51e-05 | 1440 | 150 | 19 | 30833792 | |
| Interaction | CEBPB interactions | RANBP2 SRSF4 SRSF5 SRSF6 CALU BCLAF1 CAMK2A IARS1 HSPH1 SPTBN2 RCN1 UBA2 MCM3 HNRNPUL1 RAB14 TTC1 EZH2 XAB2 YARS1 USP10 DDX46 WDHD1 XRN1 USP7 PRKAR2A PARN EIF2AK4 HCLS1 TOP3A | 5.07e-07 | 1443 | 147 | 29 | int:CEBPB |
| Interaction | CAMK2N1 interactions | 5.52e-07 | 10 | 147 | 4 | int:CAMK2N1 | |
| Interaction | PDE4A interactions | 2.37e-06 | 30 | 147 | 5 | int:PDE4A | |
| Interaction | KCTD13 interactions | ZMYND19 SRSF5 PACSIN1 TNC BCLAF1 CAMK2A IARS1 CAMK2B CAMK2D CAMK2G PCLO HSPH1 SPTBN2 RAB14 AP3B1 FMNL2 YARS1 USP10 AP3B2 XRN1 USP7 KNDC1 PRKAR2A PRKAR2B PLEKHA5 PRRC2B CACNA2D3 | 2.71e-06 | 1394 | 147 | 27 | int:KCTD13 |
| Interaction | BAP1 interactions | RANBP2 SRSF4 SRSF5 CALU CAMK2A IARS1 CAMK2D CAMK2G HSPH1 SPTBN2 RCN1 UBA2 MCM3 HMGCS1 HNRNPUL1 IPO4 RAB14 TTC1 AP3B1 YARS1 DDX46 DIAPH1 USP7 PRKAR2A PRKAR2B PACSIN2 | 2.91e-06 | 1314 | 147 | 26 | int:BAP1 |
| Interaction | CALM1 interactions | CUL1 RANBP2 SRSF5 CAMK2A CAMK2B CAMK2D CAMK2G RDH13 EZH2 DUSP22 CDC37L1 DENND4C RYR1 TRIM33 XRN1 PRKAR2B PLEKHA5 | 3.32e-06 | 626 | 147 | 17 | int:CALM1 |
| Interaction | STIP1 interactions | CUL1 RANBP2 IARS1 HSPH1 PPM1M MCM3 HNRNPUL1 IPO4 EZH2 AP3B1 CDC37L1 DENND4C TRIM33 USP10 DDX46 WDHD1 TUBGCP3 DIAPH1 USP7 PRKAR2A PPP6R3 RAD21 | 3.88e-06 | 1006 | 147 | 22 | int:STIP1 |
| Interaction | TNIK interactions | CAMK2A CAMK2B CAMK2D CAMK2G SPTBN2 GRIK2 USP10 PTPRD PRKAR2A PRKAR2B PLEKHA5 PRKG1 PRRC2B | 4.56e-06 | 381 | 147 | 13 | int:TNIK |
| Interaction | SNCA interactions | SRSF4 CALU IARS1 CAMK2G PCLO HSPH1 RCN1 IPO4 AP3B1 USP10 AP3B2 XRN1 USP7 PRKAR2A PRKAR2B TTI1 HCLS1 PPP6R3 | 4.91e-06 | 716 | 147 | 18 | int:SNCA |
| Interaction | CIBAR2 interactions | 1.30e-05 | 7 | 147 | 3 | int:CIBAR2 | |
| Interaction | CAMK2N2 interactions | 1.30e-05 | 7 | 147 | 3 | int:CAMK2N2 | |
| Interaction | RCHY1 interactions | RANBP2 CALU CAMK2A CAMK2D CAMK2G RCN1 HNRNPUL1 DDX46 PPP6R3 PMM1 RAD21 | 2.73e-05 | 325 | 147 | 11 | int:RCHY1 |
| Interaction | KMT2E interactions | 2.84e-05 | 49 | 147 | 5 | int:KMT2E | |
| Interaction | PRECSIT interactions | 3.09e-05 | 9 | 147 | 3 | int:PRECSIT | |
| Interaction | AKAP4 interactions | 3.09e-05 | 9 | 147 | 3 | int:AKAP4 | |
| Interaction | RUFY1 interactions | RANBP2 IARS1 HSPH1 UBA2 MCM3 IPO4 RAB14 FMNL2 AP3B2 DIAPH1 USP7 TTI1 ATP2A1 | 4.75e-05 | 476 | 147 | 13 | int:RUFY1 |
| Interaction | WAS interactions | 4.80e-05 | 89 | 147 | 6 | int:WAS | |
| Interaction | C9orf78 interactions | CUL1 HSPH1 CYP51A1 UBA2 HMGCS1 IPO4 AP3B1 XAB2 MRPS30 TRIM33 TUBGCP3 DIAPH1 PRKAR2B PPP6R3 RAD21 | 4.93e-05 | 620 | 147 | 15 | int:C9orf78 |
| Interaction | RSL1D1 interactions | CHL1 CUL1 SRSF4 SRSF5 SRSF6 BCLAF1 CAMK2A CAMK2B CAMK2G HSPH1 AATK USP7 PPP6R3 | 5.07e-05 | 479 | 147 | 13 | int:RSL1D1 |
| Interaction | DYRK1A interactions | B4GALT2 SRSF4 SRSF5 CAMK2D HNRNPUL1 AP3B1 WDHD1 XRN1 USP7 KNDC1 PRKAR2A PRKAR2B PLEKHA5 PARN | 5.38e-05 | 552 | 147 | 14 | int:DYRK1A |
| Interaction | PIGF interactions | 5.60e-05 | 29 | 147 | 4 | int:PIGF | |
| Interaction | KALRN interactions | 7.35e-05 | 96 | 147 | 6 | int:KALRN | |
| Interaction | MYO10 interactions | 7.96e-05 | 141 | 147 | 7 | int:MYO10 | |
| Interaction | TTC5 interactions | 1.12e-04 | 65 | 147 | 5 | int:TTC5 | |
| Interaction | PTPN7 interactions | 1.12e-04 | 65 | 147 | 5 | int:PTPN7 | |
| Interaction | WDR76 interactions | RANBP2 CAMK2A IARS1 CAMK2D HSPH1 HNRNPUL1 EZH2 AP3B1 YARS1 USP7 PRKAR2A | 1.19e-04 | 383 | 147 | 11 | int:WDR76 |
| Interaction | CNKSR2 interactions | 1.21e-04 | 66 | 147 | 5 | int:CNKSR2 | |
| Interaction | EDDM3A interactions | 1.49e-04 | 37 | 147 | 4 | int:EDDM3A | |
| Interaction | PTEN interactions | CUL1 RANBP2 CAMK2G HSPH1 RCN1 MCM3 HNRNPUL1 IPO4 RAB14 EZH2 RYR3 USP10 AATK USP7 PRKAR2A PRKAR2B RAD21 TRAPPC2 | 1.49e-04 | 929 | 147 | 18 | int:PTEN |
| Interaction | FMR1 interactions | CBLL1 RANBP2 BCLAF1 CAMK2A CAMK2B CAMK2D CAMK2G EZH2 USP10 AATK USP7 WDFY3 PRRC2B | 1.56e-04 | 536 | 147 | 13 | int:FMR1 |
| Interaction | DEFB109B interactions | 1.65e-04 | 38 | 147 | 4 | int:DEFB109B | |
| Interaction | CCDC71 interactions | 1.82e-04 | 72 | 147 | 5 | int:CCDC71 | |
| Interaction | SPA17 interactions | 1.99e-04 | 16 | 147 | 3 | int:SPA17 | |
| Interaction | MYPN interactions | 2.02e-04 | 40 | 147 | 4 | int:MYPN | |
| Interaction | TMEM132D interactions | 2.07e-04 | 74 | 147 | 5 | int:TMEM132D | |
| Cytoband | 13q12.3 | 5.03e-05 | 22 | 150 | 3 | 13q12.3 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.76e-07 | 115 | 106 | 8 | 769 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 4.15e-05 | 12 | 106 | 3 | 737 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 8.47e-05 | 15 | 106 | 3 | 1296 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.02e-04 | 3 | 106 | 2 | 287 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.62e-04 | 53 | 106 | 4 | 532 | |
| GeneFamily | EF-hand domain containing | 1.84e-03 | 219 | 106 | 6 | 863 | |
| GeneFamily | Cathepsins | 3.40e-03 | 15 | 106 | 2 | 470 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | ZMYND19 PMS1 GALE SRSF6 TNC CALU BCLAF1 IARS1 TTC39C IFIT2 YARS1 MRPS30 USP10 WDHD1 TUBGCP3 XRN1 | 3.74e-06 | 721 | 149 | 16 | M10237 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | SRSF5 SRSF6 ZFYVE16 HSPH1 RCN1 MCM3 RMI1 PTPRD HECTD2 TTC12 XRN1 MEDAG TTI1 PARN CHD6 PRKG1 WDFY3 FGGY PRRC2B | 4.81e-06 | 1009 | 149 | 19 | M157 |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 5.57e-06 | 168 | 149 | 8 | M6874 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 8.18e-06 | 177 | 149 | 8 | M39245 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP | 8.42e-06 | 127 | 149 | 7 | M40905 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | HSPH1 RCN1 MCM3 RMI1 HECTD2 XRN1 MEDAG TTI1 PARN CHD6 PRKG1 FGGY | 8.81e-06 | 441 | 149 | 12 | M172 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 1.03e-05 | 305 | 149 | 10 | M19875 | |
| Coexpression | KRAS.BREAST_UP.V1_DN | 1.83e-05 | 143 | 149 | 7 | M2887 | |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_UP | 1.91e-05 | 199 | 149 | 8 | M3314 | |
| Coexpression | GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN | 1.98e-05 | 200 | 149 | 8 | M391 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 1.98e-05 | 200 | 149 | 8 | M9922 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN | 1.98e-05 | 200 | 149 | 8 | M7418 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 2.61e-05 | 271 | 149 | 9 | MM1075 | |
| Coexpression | YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN | 5.71e-05 | 72 | 149 | 5 | M1208 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | 6.39e-05 | 378 | 149 | 10 | M17788 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 7.92e-05 | 180 | 149 | 7 | M2961 | |
| Coexpression | AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP | 8.58e-05 | 126 | 149 | 6 | M2309 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 8.78e-05 | 183 | 149 | 7 | M2993 | |
| Coexpression | NOTCH_DN.V1_UP | 9.72e-05 | 186 | 149 | 7 | M2789 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BCLAF1 IARS1 HSPH1 TTC1 AP3B1 TRIM33 RMI1 DDX46 WDHD1 PHF20L1 SKAP2 CTSV RAD21 | 9.99e-05 | 656 | 149 | 13 | M18979 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | B4GALT2 CUL1 RANBP2 TNC PIK3R3 CYP51A1 UBA2 RAB14 IFIT1 PKD2 USP7 | 1.01e-04 | 481 | 149 | 11 | M3898 |
| Coexpression | E2F1_UP.V1_UP | 1.04e-04 | 188 | 149 | 7 | M2632 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 1.19e-04 | 258 | 149 | 8 | M2446 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 1.26e-04 | 194 | 149 | 7 | M8864 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP | 1.30e-04 | 195 | 149 | 7 | M8151 | |
| Coexpression | GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP | 1.35e-04 | 196 | 149 | 7 | M5189 | |
| Coexpression | GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP | 1.39e-04 | 197 | 149 | 7 | M6575 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP | 1.43e-04 | 198 | 149 | 7 | M8649 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 1.46e-04 | 418 | 149 | 10 | M12676 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_DN | 1.48e-04 | 199 | 149 | 7 | M5729 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN | 1.48e-04 | 199 | 149 | 7 | M5712 | |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN | 1.52e-04 | 200 | 149 | 7 | M5996 | |
| Coexpression | GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP | 1.52e-04 | 200 | 149 | 7 | M9734 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP | 1.52e-04 | 200 | 149 | 7 | M9770 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_DN | 1.52e-04 | 200 | 149 | 7 | M5738 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | CAMK2B MCM3 HMGCS1 HNRNPUL1 EZH2 DDX46 WDHD1 TUBGCP3 TTI1 RAD21 | 1.70e-04 | 426 | 149 | 10 | M9516 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | CACNA2D2 TNC CAMK2D ANXA13 CYP51A1 APOA4 TTC1 RYR1 PTPRD IFT88 SIGIRR XRN1 KNDC1 CHD6 ATP2A1 | 1.94e-04 | 899 | 149 | 15 | M2242 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 2.01e-04 | 435 | 149 | 10 | MM1221 | |
| Coexpression | KRAS.600.LUNG.BREAST_UP.V1_DN | 2.29e-04 | 284 | 149 | 8 | M2885 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | CACNA2D2 TNC CAMK2D ANXA13 CYP51A1 APOA4 TTC1 RYR1 PTPRD IFT88 SIGIRR XRN1 KNDC1 CHD6 ATP2A1 | 2.79e-04 | 930 | 149 | 15 | MM893 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CBLL1 PMS1 MBTD1 SRSF4 PCLO HNRNPUL1 RAB14 TTC1 AP3B1 TRIM33 TTI1 EIF2AK4 WDFY3 EFCAB7 CRAMP1 RAD21 | 3.24e-06 | 595 | 145 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.55e-05 | 173 | 145 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | PDE3A PDE3B IL18 CACNA2D2 CAMK2D FMNL2 IFIT2 C1GALT1C1 AATK PTPRD PRKAR2A PLEKHA5 PRKG1 WDFY3 SKAP2 RAD21 TRAPPC2 | 6.01e-05 | 838 | 145 | 17 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.60e-08 | 188 | 150 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.07e-07 | 183 | 150 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 184 | 150 | 8 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 187 | 150 | 8 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 187 | 150 | 8 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-07 | 188 | 150 | 8 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.64e-07 | 189 | 150 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-07 | 190 | 150 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.98e-07 | 192 | 150 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.10e-07 | 193 | 150 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-07 | 194 | 150 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-07 | 195 | 150 | 8 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 159 | 150 | 7 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 159 | 150 | 7 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 159 | 150 | 7 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 159 | 150 | 7 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-06 | 161 | 150 | 7 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 164 | 150 | 7 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.49e-06 | 165 | 150 | 7 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-06 | 167 | 150 | 7 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-06 | 169 | 150 | 7 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 172 | 150 | 7 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 172 | 150 | 7 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.96e-06 | 172 | 150 | 7 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-06 | 176 | 150 | 7 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-06 | 178 | 150 | 7 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-06 | 178 | 150 | 7 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.96e-06 | 183 | 150 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.29e-06 | 186 | 150 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.66e-06 | 189 | 150 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.79e-06 | 190 | 150 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.92e-06 | 191 | 150 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 191 | 150 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 191 | 150 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-06 | 192 | 150 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-06 | 192 | 150 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-06 | 192 | 150 | 7 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-06 | 192 | 150 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.06e-06 | 192 | 150 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-06 | 192 | 150 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-06 | 192 | 150 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-06 | 193 | 150 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.20e-06 | 193 | 150 | 7 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-06 | 194 | 150 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-06 | 194 | 150 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 194 | 150 | 7 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 195 | 150 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 195 | 150 | 7 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.50e-06 | 195 | 150 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.65e-06 | 196 | 150 | 7 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-06 | 197 | 150 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 197 | 150 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.81e-06 | 197 | 150 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-06 | 199 | 150 | 7 | 34199597371a20d9f1dea9ad59edfb615b14c4f6 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.31e-06 | 200 | 150 | 7 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.31e-06 | 200 | 150 | 7 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.31e-06 | 200 | 150 | 7 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.34e-05 | 153 | 150 | 6 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-05 | 153 | 150 | 6 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 160 | 150 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 160 | 150 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 167 | 150 | 6 | e0f2509e86302eca8352821bce12597f6c51fc24 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 167 | 150 | 6 | b25646b6653cd8814dbeae4c74ce899ede105200 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 170 | 150 | 6 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 170 | 150 | 6 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.51e-05 | 171 | 150 | 6 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 2.51e-05 | 171 | 150 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-05 | 174 | 150 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-05 | 174 | 150 | 6 | c52aed2ffe9c648e5f23e3459e2d331d6ca214e3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 175 | 150 | 6 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 178 | 150 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 178 | 150 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 3.25e-05 | 179 | 150 | 6 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 180 | 150 | 6 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.45e-05 | 181 | 150 | 6 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.56e-05 | 182 | 150 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 3.67e-05 | 183 | 150 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.90e-05 | 185 | 150 | 6 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.02e-05 | 186 | 150 | 6 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.14e-05 | 187 | 150 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 187 | 150 | 6 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.14e-05 | 187 | 150 | 6 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 187 | 150 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 187 | 150 | 6 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.27e-05 | 188 | 150 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 188 | 150 | 6 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.27e-05 | 188 | 150 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.40e-05 | 189 | 150 | 6 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 189 | 150 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 189 | 150 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 190 | 150 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.53e-05 | 190 | 150 | 6 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 190 | 150 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 190 | 150 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 190 | 150 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | Caecum-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 4.53e-05 | 190 | 150 | 6 | 54463f6f1718f22704175bd034f134de3b55d2eb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 190 | 150 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.53e-05 | 190 | 150 | 6 | 46dfab02c1b4a403b7efc871707b6a189eefd4c4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 190 | 150 | 6 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 190 | 150 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | PDE3A CACNA2D2 CALU CAMK2B CAMK2D PIK3R3 RYR1 RYR3 PKD2 PRKAR2A PRKAR2B PRKG1 TOP3A CACNA2D3 | 1.36e-08 | 308 | 147 | 14 | CID000001915 |
| Drug | felodipine | PDE3A PDE3B IL18 CACNA2D2 CYP51A1 RYR1 RYR3 ADHFE1 PKD2 CACNA2D3 | 1.54e-07 | 169 | 147 | 10 | CID000003333 |
| Drug | dihydropyridine | CACNA2D2 CAMK2B RYR1 RYR3 ADHFE1 PKD2 PRKAR2A PRKAR2B ATP2A1 CACNA2D3 | 5.27e-07 | 193 | 147 | 10 | CID000104822 |
| Drug | calmidazolium chloride | TNC CAMK2B CAMK2D TRPC5 CYP51A1 PRKAR2A PRKAR2B PRKG1 ATP2A1 | 1.00e-06 | 160 | 147 | 9 | CID000002531 |
| Drug | lavendustin A | CACNA2D2 PIK3R3 RYR1 RYR3 PKD2 PRKAR2A PRKAR2B PRKG1 CACNA2D3 | 1.75e-06 | 171 | 147 | 9 | CID000003894 |
| Drug | CNS 1145 | 2.15e-06 | 33 | 147 | 5 | CID000190902 | |
| Drug | IHC-64 | 2.15e-06 | 33 | 147 | 5 | CID000162753 | |
| Drug | epoxiconazole | CAMK2B TTC39C CAMK2G SPTBN2 CYP51A1 GRIK2 IL1RAPL1 DDX46 MTHFR HECTD2 MORC3 CACNA2D3 | 2.31e-06 | 341 | 147 | 12 | ctd:C109476 |
| Drug | carbachol | PDE3A PDE3B CACNA2D2 CAMK2B CAMK2D CTSC PIK3R3 TRPC5 TTC1 RYR1 RYR3 PKD2 PRKAR2A PRKAR2B PRKG1 ATP2A1 CACNA2D3 | 2.33e-06 | 688 | 147 | 17 | CID000002551 |
| Drug | AC1L1GTT | CAMK2A CAMK2B CAMK2D CAMK2G NR4A1 RYR1 RYR3 PRKAR2A PRKAR2B PRKG1 | 2.90e-06 | 233 | 147 | 10 | CID000003837 |
| Drug | ML-9 | 5.22e-06 | 147 | 147 | 8 | CID000004217 | |
| Drug | N-methyl-DL-aspartic acid | CACNA2D2 CAMK2A CAMK2B CAMK2D CAMK2G PIK3R3 TRPC5 GRIK2 ADGRV1 RYR1 RYR3 PKD2 PRKAR2A PRKAR2B CACNA2D3 GABRA6 | 5.45e-06 | 655 | 147 | 16 | CID000004376 |
| Drug | Bay K 8644 | 6.06e-06 | 150 | 147 | 8 | CID000002303 | |
| Drug | fentanyl | 7.86e-06 | 111 | 147 | 7 | CID000003345 | |
| Drug | arabinosyladenine | PDE3A PDE3B IL18 GANC CACNA2D2 CALU IARS1 PIK3R3 GRIK2 YARS1 RYR1 RYR3 PKD2 PRKAR2A PRKAR2B PRKG1 ATP2A1 | 8.99e-06 | 762 | 147 | 17 | CID000000191 |
| Drug | TAS-301 | 9.06e-06 | 7 | 147 | 3 | CID009885087 | |
| Drug | PDEs | 1.05e-05 | 116 | 147 | 7 | CID003036959 | |
| Drug | AC1L1KC5 | CACNA2D2 CALU CAMK2B CAMK2D PIK3R3 TRPC5 RYR1 RYR3 PKD2 PRKAR2A PRKAR2B PRKG1 ATP2A1 CACNA2D3 | 1.14e-05 | 541 | 147 | 14 | CID000005428 |
| Drug | caffeine | PDE3A PDE3B CACNA2D2 CALU CYP51A1 GRIK2 RYR1 RYR3 PKD2 XRN1 PRKAR2A PRKAR2B ATP2A1 CACNA2D3 | 1.75e-05 | 562 | 147 | 14 | CID000002519 |
| Drug | XeC compound | 1.76e-05 | 84 | 147 | 6 | CID000005701 | |
| Drug | bepridil | 1.80e-05 | 126 | 147 | 7 | CID000002351 | |
| Drug | HF-2035 | 1.90e-05 | 25 | 147 | 4 | CID006439511 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 2.14e-05 | 233 | 147 | 9 | CID000005114 | |
| Drug | Kn 04 | 2.23e-05 | 26 | 147 | 4 | CID000131117 | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.29e-05 | 180 | 147 | 8 | 2859_DN | |
| Drug | lanthanum | 2.95e-05 | 136 | 147 | 7 | CID000023926 | |
| Drug | AC1NUZ8M | 2.95e-05 | 92 | 147 | 6 | CID000073211 | |
| Drug | rhod-2 | 3.03e-05 | 28 | 147 | 4 | CID000123669 | |
| Drug | diazo-2 | 3.03e-05 | 28 | 147 | 4 | CID005486722 | |
| Drug | Cinildipine | 3.07e-05 | 56 | 147 | 5 | CID000002752 | |
| Drug | W7 hydrochloride | 3.71e-05 | 250 | 147 | 9 | CID000005681 | |
| Drug | zaprinast | 3.72e-05 | 141 | 147 | 7 | CID000005722 | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; HL60; HT_HG-U133A | 3.90e-05 | 194 | 147 | 8 | 3021_DN | |
| Drug | rolipram | 4.07e-05 | 253 | 147 | 9 | CID000005092 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 4.14e-05 | 2 | 147 | 2 | ctd:C005147 | |
| Drug | Inocor (TN) | 4.14e-05 | 2 | 147 | 2 | CID000656683 | |
| Drug | RS-1893 | 4.14e-05 | 2 | 147 | 2 | CID000128386 | |
| Drug | nilvadipine | 4.30e-05 | 60 | 147 | 5 | CID000004494 | |
| Drug | nimodipine | 4.45e-05 | 145 | 147 | 7 | CID000004497 | |
| Drug | Dantrolene-13C3 | 4.45e-05 | 145 | 147 | 7 | CID000002951 | |
| Drug | AC1MBZ1C | PDE3A PDE3B CALU CAMK2B CAMK2D PIK3R3 NR4A1 PRKAR2A PRKAR2B PRKG1 ATP2A1 | 4.46e-05 | 387 | 147 | 11 | CID000003541 |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 3638_UP | |
| Drug | M-HN | 4.58e-05 | 31 | 147 | 4 | CID000015450 | |
| Drug | IAA-94 | 4.66e-05 | 61 | 147 | 5 | CID000003667 | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 3307_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 3928_DN | |
| Drug | Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; HL60; HG-U133A | 4.67e-05 | 199 | 147 | 8 | 1554_DN | |
| Drug | C070379 | 4.67e-05 | 199 | 147 | 8 | CID003034747 | |
| Drug | Clozapine | CHL1 CAMK2A CAMK2B CAMK2D PIK3R3 GRIK2 HMGCS1 NR4A1 MTHFR PRKAR2A PRKAR2B | 4.78e-05 | 390 | 147 | 11 | ctd:D003024 |
| Drug | BAPTA | CAMK2B CAMK2D TRPC5 RYR1 RYR3 PRKAR2A PRKAR2B PRKG1 ATP2A1 GABRA6 | 5.04e-05 | 324 | 147 | 10 | CID000104751 |
| Drug | mercury | PDE3A CACNA2D2 PIK3R3 ANXA13 RENBP RYR1 RYR3 PKD2 ATP2A1 CRAMP1 CACNA2D3 PMM1 GABRA6 | 5.20e-05 | 542 | 147 | 13 | CID000023931 |
| Drug | lercanidipine | 5.45e-05 | 63 | 147 | 5 | CID000065866 | |
| Drug | milrinone | 5.52e-05 | 150 | 147 | 7 | CID000004197 | |
| Drug | sulmazole | 5.56e-05 | 12 | 147 | 3 | CID000005353 | |
| Drug | Ryanodine | 5.56e-05 | 12 | 147 | 3 | ctd:D012433 | |
| Drug | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | B4GALT2 ZMYND19 MBTD1 GALE IL18 BCLAF1 CTSC HSPH1 MCM3 YARS1 WDHD1 CHD6 SKAP2 | 5.61e-05 | 546 | 147 | 13 | ctd:C532162 |
| Drug | mibefradil | 5.88e-05 | 64 | 147 | 5 | CID000060662 | |
| Drug | loperamide | 6.22e-05 | 105 | 147 | 6 | CID000003954 | |
| Drug | prochloraz | CAMK2B CAMK2G SPTBN2 CYP51A1 GRIK2 IL1RAPL1 IFT88 SKAP2 CACNA2D3 | 6.35e-05 | 268 | 147 | 9 | ctd:C045362 |
| Drug | AC1L1KS5 | CACNA2D2 PIK3R3 TRPC5 RYR1 RYR3 PKD2 PRKAR2A PRKAR2B ATP2A1 CACNA2D3 | 6.50e-05 | 334 | 147 | 10 | CID000005631 |
| Drug | OPC 3911 | 7.19e-05 | 13 | 147 | 3 | CID000131164 | |
| Drug | gallopamil | 7.33e-05 | 67 | 147 | 5 | CID000001234 | |
| Drug | Haloperidol | CHL1 CAMK2A CAMK2B CAMK2D PIK3R3 GRIK2 HMGCS1 NR4A1 PRKAR2A PRKAR2B | 7.90e-05 | 342 | 147 | 10 | ctd:D006220 |
| Drug | AC1L2AC7 | 8.45e-05 | 69 | 147 | 5 | CID000068733 | |
| Drug | thiopental | 8.91e-05 | 112 | 147 | 6 | CID003000715 | |
| Drug | 8-aminohexylamino-cAMP | 9.11e-05 | 14 | 147 | 3 | CID000001906 | |
| Drug | NP-EGTA | 9.11e-05 | 14 | 147 | 3 | CID000183793 | |
| Drug | Thimerosal | SRSF4 PACSIN1 BCLAF1 TTC39C PCLO MIER3 GRIK2 ADGRV1 NR4A1 FMNL2 INO80D CDC37L1 RYR3 USP10 PHF20L1 HECTD2 TUBGCP3 MEDAG PLEKHA5 WDFY3 | 9.19e-05 | 1199 | 147 | 20 | ctd:D013849 |
| Drug | CAS 298-57-7 | 1.11e-04 | 73 | 147 | 5 | CID000002761 | |
| Drug | Gvapspat amide | 1.13e-04 | 15 | 147 | 3 | CID000125015 | |
| Drug | AC1NBU2S | 1.14e-04 | 117 | 147 | 6 | CID004473765 | |
| Drug | P-NE | 1.17e-04 | 169 | 147 | 7 | CID000446755 | |
| Drug | ethosuximide | 1.18e-04 | 74 | 147 | 5 | CID000003291 | |
| Drug | SureCN4406168 | 1.24e-04 | 3 | 147 | 2 | CID011502028 | |
| Drug | SureCN4395097 | 1.24e-04 | 3 | 147 | 2 | CID011610011 | |
| Drug | SureCN4401117 | 1.24e-04 | 3 | 147 | 2 | CID011718172 | |
| Drug | SureCN4402206 | 1.24e-04 | 3 | 147 | 2 | CID011516917 | |
| Drug | WIN 62582 | 1.24e-04 | 3 | 147 | 2 | CID005487388 | |
| Drug | SureCN4397066 | 1.24e-04 | 3 | 147 | 2 | CID011538627 | |
| Drug | SureCN4401121 | 1.24e-04 | 3 | 147 | 2 | CID011611819 | |
| Drug | cis-diammineplatinum(II | 1.24e-04 | 3 | 147 | 2 | CID000159790 | |
| Drug | SureCN4404748 | 1.24e-04 | 3 | 147 | 2 | CID011502895 | |
| Drug | 2-hydroxyheptanoic acid | 1.24e-04 | 3 | 147 | 2 | CID002750949 | |
| Drug | SureCN4411688 | 1.24e-04 | 3 | 147 | 2 | CID011523192 | |
| Drug | 8N3-cADPR | 1.24e-04 | 3 | 147 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.24e-04 | 3 | 147 | 2 | CID009570289 | |
| Drug | SureCN4405038 | 1.24e-04 | 3 | 147 | 2 | CID011546172 | |
| Drug | SureCN4405912 | 1.24e-04 | 3 | 147 | 2 | CID011682920 | |
| Drug | pelrinone | 1.24e-04 | 3 | 147 | 2 | CID000055919 | |
| Drug | SureCN4398032 | 1.24e-04 | 3 | 147 | 2 | CID011532088 | |
| Drug | 2-hydroxycarbazole | 1.24e-04 | 3 | 147 | 2 | CID000093551 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.24e-04 | 3 | 147 | 2 | CID000080262 | |
| Drug | form bis | 1.24e-04 | 3 | 147 | 2 | CID000006411 | |
| Drug | SureCN4406373 | 1.24e-04 | 3 | 147 | 2 | CID011711104 | |
| Drug | SureCN4394894 | 1.24e-04 | 3 | 147 | 2 | CID011711103 | |
| Drug | SureCN5995113 | 1.24e-04 | 3 | 147 | 2 | CID011640499 | |
| Drug | CHEMBL219123 | 1.24e-04 | 3 | 147 | 2 | CID016102624 | |
| Drug | germitrine | 1.24e-04 | 3 | 147 | 2 | CID000011217 | |
| Drug | SureCN4411840 | 1.24e-04 | 3 | 147 | 2 | CID011567407 | |
| Drug | flubendiamide | 1.24e-04 | 3 | 147 | 2 | CID011193251 | |
| Disease | heart conduction disease (implicated_via_orthology) | 5.01e-07 | 32 | 146 | 5 | DOID:10273 (implicated_via_orthology) | |
| Disease | brain age measurement | 2.62e-06 | 20 | 146 | 4 | EFO_0010602 | |
| Disease | X-linked spondyloepiphyseal dysplasia tarda (implicated_via_orthology) | 2.43e-05 | 2 | 146 | 2 | DOID:0080362 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 1.71e-04 | 22 | 146 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | eye disease (is_implicated_in) | 2.41e-04 | 5 | 146 | 2 | DOID:5614 (is_implicated_in) | |
| Disease | colon adenocarcinoma (is_marker_for) | 2.52e-04 | 25 | 146 | 3 | DOID:234 (is_marker_for) | |
| Disease | urate measurement, bone density | PDE3B CAMK2D KATNAL1 PTPRD DIAPH1 PRKAR2A PRKAR2B EIF2AK4 SKAP2 PRRC2B GABRA6 | 2.70e-04 | 619 | 146 | 11 | EFO_0003923, EFO_0004531 |
| Disease | congestive heart failure (is_implicated_in) | 3.18e-04 | 27 | 146 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | susceptibility to rheumatic fever measurement | 3.55e-04 | 28 | 146 | 3 | EFO_0008416 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 3.60e-04 | 6 | 146 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | Endometrial Carcinoma | 4.56e-04 | 72 | 146 | 4 | C0476089 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 5.81e-04 | 33 | 146 | 3 | DOID:4467 (is_marker_for) | |
| Disease | lean body mass | 6.23e-04 | 379 | 146 | 8 | EFO_0004995 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 6.68e-04 | 8 | 146 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Leukemia, Megakaryoblastic, of Down Syndrome | 6.68e-04 | 8 | 146 | 2 | C1860789 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 6.80e-04 | 80 | 146 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | colorectal carcinoma (is_marker_for) | 8.15e-04 | 37 | 146 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | Developmental delay (disorder) | 8.15e-04 | 37 | 146 | 3 | C0424605 | |
| Disease | obesity (biomarker_via_orthology) | 8.42e-04 | 147 | 146 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | breast cancer | 8.56e-04 | 9 | 146 | 2 | MONDO_0007254 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.78e-04 | 152 | 146 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | meningitis | 1.30e-03 | 11 | 146 | 2 | MONDO_0021108 | |
| Disease | epilepsy (implicated_via_orthology) | 1.33e-03 | 163 | 146 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | COL5A2 IL18 ZFYVE16 CAMK2D RCN1 APOA4 RDH13 ADHFE1 PTPRD PKD2 SKAP2 | 1.68e-03 | 774 | 146 | 11 | C0023893 |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.11e-03 | 181 | 146 | 5 | DOID:684 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.13e-03 | 14 | 146 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | monoclonal gammopathy | 2.32e-03 | 53 | 146 | 3 | EFO_0000203 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.32e-03 | 53 | 146 | 3 | C4707243 | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.45e-03 | 15 | 146 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.45e-03 | 15 | 146 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.45e-03 | 15 | 146 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.45e-03 | 15 | 146 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.45e-03 | 15 | 146 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.45e-03 | 15 | 146 | 2 | C0079758 | |
| Disease | Schizoaffective disorder-bipolar type | 2.79e-03 | 16 | 146 | 2 | EFO_0009965 | |
| Disease | 5-oxoproline measurement | 2.79e-03 | 16 | 146 | 2 | EFO_0010988 | |
| Disease | osteosarcoma (is_implicated_in) | 2.79e-03 | 16 | 146 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | Vascular Diseases | 3.15e-03 | 17 | 146 | 2 | C0042373 | |
| Disease | Malignant neoplasm of endometrium | 3.53e-03 | 18 | 146 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 3.53e-03 | 18 | 146 | 2 | C0346191 | |
| Disease | skin sensitivity to sun | 3.93e-03 | 19 | 146 | 2 | EFO_0004795 | |
| Disease | Lymphoma, Follicular | 4.36e-03 | 20 | 146 | 2 | C0024301 | |
| Disease | synophrys measurement | 4.70e-03 | 68 | 146 | 3 | EFO_0007906 | |
| Disease | gestational age, birth measurement | 4.80e-03 | 21 | 146 | 2 | EFO_0005112, EFO_0006921 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KYFEEGLQDGNDTFA | 166 | Q7Z4L5 | |
| NVGFLEALKEDAAYD | 196 | O60909 | |
| VQLFDDNGYVKDVEA | 766 | Q5SY80 | |
| FLITDDEEYADNFGK | 316 | Q96L12 | |
| DGGEDRVQDVFEKYN | 401 | Q9NY47 | |
| ELQALEAIYGADFQD | 26 | Q9P2K8 | |
| AFQYVKENGGLDSEE | 186 | O60911 | |
| ETDGINYLVDDFANA | 1616 | Q8WXG9 | |
| DKNADGFIDLEEYIG | 201 | O43852 | |
| VDKDLAGQDAKDLYD | 166 | P27216 | |
| EELEGEAEGYLVFKQ | 506 | Q9NR19 | |
| KDEYDDLAESEQFGV | 911 | O60610 | |
| CLKYAGVFAENAEDA | 226 | Q96EU7 | |
| NDSSLDFNEAKGVYE | 421 | O14983 | |
| DFNEAKGVYEKVGEA | 426 | O14983 | |
| KEGDELEDNGKNFYE | 261 | O00203 | |
| LEDNGKNFYESDDDQ | 266 | O00203 | |
| LEENAEKAFYGSEED | 261 | Q13367 | |
| EKAFYGSEEDEAKGA | 266 | Q13367 | |
| VDQAELEKYDGVDAG | 31 | Q01581 | |
| DKNGDGFVDQDEYIA | 216 | Q15293 | |
| YEEAKQFAEENGLLF | 136 | P61106 | |
| QSIYGDKFEDENFDV | 3136 | P49792 | |
| YEDQYKDDNFGEGND | 211 | O60216 | |
| YQAIEEADFFAIDGE | 16 | O95453 | |
| GKEDAGDVQQFYDLL | 396 | P22736 | |
| LFQDKLGEVNTYAGD | 61 | P06727 | |
| EKQKEGYGDALLFDE | 516 | Q6TGC4 | |
| QLGEADEELAGKYAE | 201 | P51606 | |
| EEEEGGFNYAVDLVK | 166 | P42898 | |
| KINENADGSFDYGLF | 61 | O75951 | |
| GDLYFANVEEKDSRN | 186 | O00533 | |
| KEELLDGEDYNFLQG | 596 | Q05BQ5 | |
| GGLDDVSNKAYEDAE | 326 | Q13976 | |
| EDSGINAKFVNAVYD | 181 | Q5U5R9 | |
| LYEEGEDQAKQAYVD | 676 | Q92598 | |
| LDYFALGGNKQALEE | 71 | Q53HL2 | |
| THAFDDQGREYDKEG | 651 | P0DPD6 | |
| FVELVNALGQYNDDD | 171 | Q15910 | |
| YKQEDSQGSGEEEDF | 1541 | Q9Y6V0 | |
| NHFGAEELDGDNKDY | 391 | Q9NZN1 | |
| SQFENSVYKGDDDDE | 561 | Q14149 | |
| GFEDDGTDKDTNFYV | 3286 | Q02505 | |
| DGIVNEFYEQGDEEA | 966 | Q14432 | |
| VNEFYEQGDEEANLG | 956 | Q13370 | |
| NYEDEQDVKAVDAGF | 371 | Q8TET4 | |
| NEEQEYKRAFDLGAT | 281 | Q8N9F7 | |
| NALGKLEVEGNFYSE | 16 | Q16445 | |
| LENAFQGKIDAAYFE | 526 | Q96CW5 | |
| GDYNGENVEFNDRKL | 286 | Q5XXA6 | |
| GEYDGNEKVYENEDQ | 191 | Q7Z3K6 | |
| AAGEQDDFYEVSLDN | 646 | A6NDN3 | |
| ARNEGEGAYEAELFV | 676 | P53708 | |
| NGENLSFAYEFKADA | 186 | Q5VYS4 | |
| VAEELADVSGKYFDG | 276 | Q8NBN7 | |
| YDGQEQDELSFKAGD | 396 | Q9BY11 | |
| SKEDYYGNGKDDEEQ | 506 | Q16821 | |
| NEEERYDCKGGELFA | 66 | Q75N03 | |
| NGTDDKSIYGEKFDD | 71 | A0A075B767 | |
| DFLDDEEDQGIYQSK | 21 | P25205 | |
| VKFSDDVIDNGNYDI | 631 | Q96MT3 | |
| DYEGQEHDELSFKAG | 436 | Q9UNF0 | |
| GIKNEDADENYFINE | 331 | Q92569 | |
| EALNVFGNDYDTEDG | 221 | Q14376 | |
| DNYKELLGGVDNAFL | 81 | Q8TED4 | |
| GNTVFANGDYEKAAE | 491 | Q13099 | |
| IINLADVNADGKFDY | 146 | A8K855 | |
| LGDDDFFNIIAYNEE | 286 | Q8IZS8 | |
| KYNEDLDFKVVDDDG | 246 | Q8TD26 | |
| GLEDFVADNYSKIGN | 211 | Q96C11 | |
| DFELQGYAFEAAEEQ | 51 | Q9UBR1 | |
| QSYVELGLNEDDAFA | 206 | Q13616 | |
| EDQEALDYFSDKESG | 376 | Q9NYF8 | |
| NEKVAQLYADLDGGF | 226 | Q16850 | |
| EGLYEHGKDFEAIQN | 176 | Q96RY5 | |
| IAGKYAQDFGLVEEA | 306 | P53634 | |
| DQGYGSKDELIKDDA | 916 | Q5VZ89 | |
| AAGEQDDFYEVSLDN | 646 | A6NDK9 | |
| FVSIKAQEEDEDEGY | 21 | P05997 | |
| YLDNVFDVGALLEDA | 371 | Q96PY5 | |
| GLYIGNFKDARDAEQ | 11 | Q9NRW4 | |
| GQEAEGEKYIEEALA | 231 | P09914 | |
| EGENSLDDFEDKVFY | 26 | P09913 | |
| DLQDFDFFEGKNGDL | 631 | Q53TQ3 | |
| VIDQGDDGDNFYVIE | 166 | P13861 | |
| VIDQGDDGDNFYVID | 181 | P31323 | |
| QEEFAFDGYLDNGLE | 901 | Q76NI1 | |
| HAFDDQGREYDKDGN | 611 | P42892 | |
| DENGKSFAVVLYADF | 56 | Q5T890 | |
| QDGGQNESFKRYEEE | 921 | Q7L014 | |
| RLVEDGKYGAQDDAN | 481 | Q13002 | |
| IAEDDENLESDYFGK | 26 | Q14116 | |
| VKFENFEDAALEENG | 36 | Q8WTZ4 | |
| DVELGADELAYVFNG | 1111 | P21817 | |
| SGYSVENAFFDEKED | 661 | Q8TEX9 | |
| NYGFDKIEVRDNGEG | 46 | P54277 | |
| TDDYQLFEELGKGAF | 11 | Q13555 | |
| EEEGYFEAFKNELEA | 251 | Q7L3B6 | |
| TDEYQLFEELGKGAF | 11 | Q13557 | |
| NYELVYKDGEHGEEQ | 546 | P23468 | |
| FENYGDKFAENDVIG | 316 | Q9BUJ2 | |
| GVDGAEKKEDYNETA | 291 | A8MW92 | |
| EAIEFAQKGAFDAYV | 121 | Q8IWW8 | |
| VGEYEADKQAELAYN | 386 | Q6P4E1 | |
| ADKQAELAYNEEEDG | 391 | Q6P4E1 | |
| LYETIEDNDVKGFND | 401 | Q9NP92 | |
| FDGAGYDKDLVEALE | 181 | Q9BW62 | |
| IEAVNNGDFEAYAKI | 546 | Q13554 | |
| VDLKNGYGFVEFDDL | 31 | Q08170 | |
| FAKFYEDNGQLDDAR | 401 | Q9HCS7 | |
| EVAQAGKAVALYFED | 1061 | Q9UPN9 | |
| ALDEEYLKVDAQFGG | 171 | P54577 | |
| ADKSAVGFDYKGEVE | 131 | P14317 | |
| GFKEFENAEGDEYAA | 61 | Q6ZMQ8 | |
| KVGGSDAEDDDEYNR | 226 | Q9C056 | |
| GGEVDALLEEYAQEK | 191 | Q9H9A7 | |
| QEFQDKGDAEDGEEY | 61 | O75563 | |
| GADETNDDNKEYDAY | 391 | Q9NP60 | |
| NAYIEAEVKGSEDDG | 61 | Q9Y2K3 | |
| DKNGDNTIDFLEYVA | 66 | Q9UMX6 | |
| QDAYGEVEINDGKLY | 151 | Q6IA17 | |
| YLFNQLFGEEDADQE | 191 | Q9UBT2 | |
| EVTDFAGQYVKDADK | 361 | P41252 | |
| VDLKNGYGFVEFEDS | 31 | Q13247 | |
| EEYQLFEELGKGAFS | 11 | Q9UQM7 | |
| EQLGDGDEVIEKFDY | 61 | Q92871 | |
| EGVVEFASYGDLKNA | 146 | Q13243 | |
| YFAGDDEGIQEKLLQ | 791 | O75969 | |
| KDFYDEEINEGALVN | 381 | Q8NB49 | |
| EVDADGNGAKIFAYA | 41 | Q96E35 | |
| DEKDGFIFVNYSEGQ | 3341 | Q8IZQ1 | |
| QDGKEYLFQAKDEAE | 2301 | O15020 | |
| NKGSELAFADYEIEN | 1171 | Q15413 | |
| SSRVEKDYNDLFDGD | 316 | O75717 | |
| AGYAEIINAEKSEFN | 71 | Q96MI6 | |
| YLNGDKAEALEVFCD | 2001 | P24821 | |
| GNKYLNEAAGVAAEE | 366 | Q8IZH2 | |
| GEEYLSAFDKKAQAD | 801 | Q5JSZ5 | |
| EAIFTKYDQDGDQEL | 756 | Q13563 | |
| KLDEALAQYFGNGTE | 626 | Q13472 | |
| QEDGIKNFFTDVYDL | 91 | P0DI81 | |
| SEKGRQEDAEEYLGF | 516 | Q14694 | |
| EKGNEAFAEGNYETA | 111 | Q9H892 | |
| AEEKAFLNAVEKGDY | 31 | Q9UL62 | |
| NKEDGEILGFDIYSQ | 811 | Q9BXT5 | |
| EAQEFVEKYEGALGK | 186 | Q8TDI7 | |
| LQAKEDFSGYDFENR | 551 | Q8N584 | |
| ALEAEKYGFQKDGQD | 321 | Q9HAU0 | |
| QEDGIKNFFTDVYDL | 91 | P0DI82 | |
| EEGNEQFKKGDYIEA | 121 | Q99614 | |
| DEKFADQDDIGNVSF | 566 | Q5H9R7 | |
| DYVAVEQLDGDNKYD | 366 | Q93009 | |
| QDLDYFNIDEGAKSG | 511 | Q7Z3T8 | |
| YLKEKDVADGNVSDF | 816 | O43156 |